Literature DB >> 15820329

Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries.

Mirella Ruggeri1, Maarten Koeter, Aart Schene, Chiara Bonetto, Josè Luis Vàzquez-Barquero, Thomas Becker, Martin Knapp, Helle Charlotte Knudsen, Michele Tansella, Graham Thornicroft.   

Abstract

RATIONALE: The expanded version of the Brief Psychiatric Rating Scale (BPRS-E) has improved the instrument's coverage and interrater reliability, but there is little knowledge on its subsyndromes.
OBJECTIVES: To assess: (1) whether there are common underlying BPRS-E subscales in patients living in different countries and (2) if this is the case, whether these subscales behave the same in all populations and, if not, what are the differences over these populations.
METHODS: Data are part of the EPSILON study, a collaborative project carried out in Denmark, England, Holland, Italy and Spain. A random representative sample of 404 adult patients with a ICD-10 diagnosis of schizophrenia who have been in contact with mental health services of a defined catchment area in each site were assessed. Simultaneous component analysis (SCA) was used to find component weights that optimally explain the variance of the variables in different populations simultaneously.
RESULTS: Symptom severity differed significantly among the five EPSILON sites in 12 out of 24 BPRS-E items, but a common component solution could be found. It explained 48.8% of the variance and gave four well-interpretable components: manic excitement/disorganization, depression/anxiety, negative and positive symptoms. Each component's internal consistency and intercomponent correlation matrix differed significantly among sites. The four components mean score differed significantly among sites for negative symptoms and depression/anxiety.
CONCLUSIONS: In spite of the heterogeneity of symptom's severity in the various countries, the way symptoms cluster in schizophrenia is rather stable cross-culturally. Data demonstrate that to explore schizophrenia a third component, including mania/disorganization items, is necessary beside the positive-negative symptom dimensions. The subscales derived from these analyses can be readily used in clinical trials and epidemiological studies.

Entities:  

Mesh:

Year:  2005        PMID: 15820329     DOI: 10.1016/j.schres.2004.05.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  27 in total

1.  Impact of psychosis on Portuguese caregivers: a cross-cultural exploration of burden, distress, positive aspects and clinical-functional correlates.

Authors:  Manuel Gonçalves-Pereira; Miguel Xavier; Bob van Wijngaarden; Ana L Papoila; Aart H Schene; José Miguel Caldas-de-Almeida
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-05-31       Impact factor: 4.328

2.  The Brief Psychiatric Rating Scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression.

Authors:  Adriano Zanello; Laurent Berthoud; Joseph Ventura; Marco C G Merlo
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

Review 3.  Psychometric evaluation of the negative syndrome of schizophrenia.

Authors:  Maria Paz Garcia-Portilla; Leticia Garcia-Alvarez; Pilar A Saiz; Susana Al-Halabi; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; José Muñiz; Julio Bobes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

4.  Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.

Authors:  Dominik A Moser; Gaelle E Doucet; Won Hee Lee; Alexander Rasgon; Hannah Krinsky; Evan Leibu; Alex Ing; Gunter Schumann; Natalie Rasgon; Sophia Frangou
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

5.  The predictive validity of subjective adherence measures in patients with schizophrenia.

Authors:  Martijn J Kikkert; Maarten W J Koeter; Jack J M Dekker; Lorenzo Burti; Debbie Robson; Bernd Puschner; Aart H Schene
Journal:  Int J Methods Psychiatr Res       Date:  2011-06       Impact factor: 4.035

6.  Association of treatment satisfaction and psychopathological sub-syndromes among involuntary patients with psychotic disorders.

Authors:  Michelle Richardson; Christina Katsakou; Stefan Priebe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-05-22       Impact factor: 4.328

7.  Development and Validation of the Health of the Nation Outcome Scales-Residential Facility (HoNOS-RF).

Authors:  Laura Pedrini; Mariangela Lanfredi; Clarissa Ferrari; Sonia Andreose; Pasquale Basso; Rossella Beneduce; Rosaria Pioli; Luciana Rillosi; Giuseppe Rossi; Roberta Rossi; Giovanni Battista Tura
Journal:  Psychiatr Q       Date:  2018-06

8.  Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia.

Authors:  Carin J Meijer; Maarten W J Koeter; Mirjam A G Sprangers; Aart H Schene
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-10-30       Impact factor: 4.328

9.  Progressive reduction of visual P300 amplitude in patients with first-episode schizophrenia: an ERP study.

Authors:  Naoya Oribe; Yoji Hirano; Shigenobu Kanba; Elisabetta Del Re; Larry Seidman; Raquelle Mesholam-Gately; Jill M Goldstein; Martha Shenton; Kevin M Spencer; Robert W McCarley; Margaret Niznikiewicz
Journal:  Schizophr Bull       Date:  2014-06-09       Impact factor: 9.306

10.  Neurocognitive abnormalities during comprehension of real-world goal-directed behaviors in schizophrenia.

Authors:  Tatiana Sitnikova; Donald Goff; Gina R Kuperberg
Journal:  J Abnorm Psychol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.